![]() |
市場調査レポート
商品コード
1371934
麻酔機器市場の2030年までの予測:タイプ別、用途別、エンドユーザー別、地域別の世界分析Anesthesia Equipment Market Forecasts to 2030 - Global Analysis By Type, Application, End User and By Geography |
||||||
カスタマイズ可能
|
麻酔機器市場の2030年までの予測:タイプ別、用途別、エンドユーザー別、地域別の世界分析 |
出版日: 2023年10月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
|
Stratistics MRCによると、世界の麻酔装置市場は2023年に83億米ドルを占め、予測期間中にCAGR 8.6%で成長し、2030年には147億7,000万米ドルに達する見込みです。
麻酔機器として知られる医療用具や器具の特定のセットは、外科手術やその他の医療処置中に麻酔を提供し、監視するために使用されます。ガスや注射薬などの麻酔薬を患者に安全かつ正確に投与し、意識を失わせ、痛みを和らげ、筋肉を弛緩させるための重要な装置です。一般的に麻酔機器は、麻酔薬の濃度や流量を調節する装置や、酸素濃度、血圧、心拍数などのバイタル指標をモニターする装置で構成されています。
WHOによると、がんは世界の死因の第1位であり、2020年には推定1,000万人が死亡しています。
最新の麻酔技術により、麻酔薬の投与が正確かつ規定され、最適な投与量が確保され、投薬ミスの可能性が低くなります。さらに、患者制御鎮痛装置や標的制御注入ポンプなどのドラッグデリバリー技術の向上により、各患者のニーズに特化したカスタマイズされた麻酔薬投与が可能になります。したがって、こうした側面が市場規模を押し上げています。
先進的な麻酔機器の開発および製造には、研究、材料、技術への多額の投資が必要であり、これらのコストはヘルスケアプロバイダーに頻繁に転嫁されるため、機器は高価です。さらに、予算の制約により、特に資源が限られている環境では、ヘルスケア施設や臨床医が最新技術への投資を行うことができず、市場の成長を妨げる可能性があります。
麻酔機器の開発によってもたらされる技術の進歩は、患者ケアをさらに向上させる。データ分析、意思決定支援、予測モデリングは、人工知能(AI)と機械学習(ML)アルゴリズムの統合によって可能になり、麻酔科医が賢明な選択を行い、より効果的に麻酔を提供し、患者の転帰を高めるのに役立っています。さらに、麻酔に使用される機器は、さまざまな手術や患者群に対応できるように作られています。そのため、鎮静、局所麻酔、全身麻酔など、さまざまな麻酔治療に柔軟に対応できます。
国内外に多くの販売業者が存在するため、市場競争は激しいです。一方、中小規模の業者は、限られた製品に加え、資金力や技術力も限られています。その結果、品質、信頼性、研究開発の面で、多くのプロバイダーは有名ベンダーに及ばないです。したがって、予測期間中は、こうした要因が市場の拡大を抑制すると思われます。
COVID-19パンデミックの発生は、世界経済とヘルスケアシステムに大きな影響を与えました。パンデミックの初期には、世界中のヘルスケア施設がCOVID-19症例の増加を理由に選択的手術の実施を中止しました。さらに、パンデミックのために多くの人々が病院に行くことを避け、処置が遅れ、患者のモニタリングや慢性疾患の治療が大きく中断されました。そのため、麻酔機器市場、製造およびサプライチェーンは、互換性のない製品需要や最終消費者への機器の納期遵守などの課題に対処しなければならなかっています。
麻酔ディスポーザブル分野は、医療施設の清潔さを保ち、感染の拡大を抑えるために不可欠な使い捨てアイテムのため、最大のシェアを占めると推定されます。喉頭マスク、呼吸回路、気管内チューブ、フィルターなどはその一例です。さらに、1回限りの使用であるため、交差汚染の危険性が少なく、滅菌の必要もないです。そのため、患者の安全性と感染対策が重視されるようになり、麻酔機器市場のこの分野は着実に拡大しています。
予測期間中、心臓病学分野のCAGRが最も高くなると予測されています。心臓麻酔には、心臓の処置や介入における麻酔の供給と監視が含まれます。このセグメントの機器には、経食道心エコー(TEE)プローブ、心拍出量モニター、心電図(ECG)などの高度な心機能モニタリングツールが含まれます。さらに、麻酔科医が課題の多い心臓手術において患者の安全性と正確な麻酔管理を保証するためには、これらの機器が不可欠です。したがって、心臓病学と心臓血管医学の分野で患者の転帰と安全性を向上させるために、心臓病学分野では心臓処置に関連する特別な要件と困難に対処しています。
北米は、強力なヘルスケアインフラ、最先端の医療施設、北米全域での大規模な手術の恩恵により、予測期間中に最大の市場シェアを占めました。さらに、最新の麻酔システムの採用は、規制遵守と厳格な安全要件の順守によって推進されています。北米における卓越した麻酔機器への絶え間ないニーズは、人口の高齢化とヘルスケアコストの上昇によってさらに加速しています。同市場には有名な麻酔機器サプライヤーが多数存在し、技術革新の重要性が増しています。したがって、こうした側面が市場の拡大に寄与しています。
ヘルスケアインフラ、厳格な規制基準、高度な麻酔ソリューションに対する需要の高まりにより、欧州は予測期間中に最も高いCAGRを示すと予想されます。欧州の医療システムの多くは品質と効率を優先しているため、欧州は世界の麻酔機器市場において重要かつ競合的な地域です。そのため、モニタリング装置やデリバリーシステムなど、最先端の麻酔機器に対する需要が常に高まっています。
Table Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
According to Stratistics MRC, the Global Anesthesia Equipment Market is accounted for $8.30 billion in 2023 and is expected to reach $14.77 billion by 2030 growing at a CAGR of 8.6% during the forecast period. A specific set of medical tools and instruments known as anesthesia equipment is used to deliver and monitor anesthesia during surgical procedures and other medical treatments. These crucial devices that ensure the safe and accurate administration of anesthetic agents, such as gases and injectable drugs, to patients in order to cause unconsciousness, relieve pain, and relax their muscles. In general, anesthesia equipment consists of devices that regulate the concentration and flow of anesthetic chemicals as well as monitors for vital indicators including oxygen levels, blood pressure, and heart rate.
According to the WHO, cancer is the leading cause of death globally and was responsible for an estimated 10 million deaths in 2020.
Modern anesthetic technology allows for accurate and regulated anesthesia drug administration, ensuring optimal dosage and lowering the possibility of medication errors, this result in increased patient comfort and quicker healing times. Additionally, improvements in drug delivery technologies, such as patient-controlled analgesia devices and target-controlled infusion pumps, enable customized anesthetic delivery that is specialized to the needs of each patient. Therefore, these aspects propel the market size.
Advanced anesthetic equipment development and manufacturing demand large investments in research, materials, and technology, the equipment is expensive since these costs are frequently transferred to healthcare providers. Furthermore, budget restrictions may prevent healthcare facilities and clinicians, particularly in environments with limited resources, from making investments in modern technology which hampers the growth of the market.
The advancements in technology brought forth by the ongoing development of anesthetic equipment further enhance patient care. Data analysis, decision support, and predictive modelling are made possible through the integration of artificial intelligence (AI) and machine learning (ML) algorithms, this helps anaesthesiologists make wise choices, deliver anesthesia more effectively, and enhance patient outcomes. Moreover, the equipment used in anesthesia is made to accommodate a variety of operations and patient groups. Thus, it provides flexibility in terms of various anesthetic treatments, such as sedation, regional anesthesia, and general anesthesia.
The market is competitive since there are many local, national, and international sellers. On the other hand, small and medium-sized suppliers have limited financial and technical capabilities in addition to limited product offerings. As a result, in terms of quality, dependability, and R&D, many providers fall short of well-known vendors. Therefore, during the projection period, these factors will restrain market expansion.
The development of the COVID-19 pandemic had a significant effect on the world economy and healthcare system. Early on in the pandemic, healthcare facilities all across the world stopped performing elective procedures because of the rising number of COVID-19 cases. Moreover, due to the pandemic, many people avoided going to hospitals, procedures were delayed, and patient monitoring and chronic illness treatment were severely disrupted. Therefore, the market for anesthetic equipment, the manufacturing and supply chain had to deal with challenges such as incompatible product demand and on-time delivery of devices to end consumers.
The anesthesia disposables segment is estimated to hold the largest share, due to the disposable items which are essential for preserving cleanliness and limiting the spread of infections in medical facilities. Laryngeal masks, breathing circuits, endotracheal tubes, and filters are just a few examples. Moreover, due to their one-time-use design, they pose less of a danger of cross-contamination and don't require sterilization. Therefore, with a growing emphasis on patient safety and infection control, this sector of the anesthetic equipment market is expanding steadily.
The cardiology segment is anticipated to have highest CAGR during the forecast period. Cardiac anesthesia entails the delivery and supervision of anesthesia during heart procedures and interventions. This segment's equipment includes sophisticated heart function monitoring tools like transesophageal echocardiography (TEE) probes, cardiac output monitors, and electrocardiograms (ECGs). Additionally, for anaesthesiologists to guarantee patient security and accurate anesthetic management during challenging cardiac procedures, these instruments are essential. Therefore, in order to improve patient outcomes and safety in the fields of cardiology and cardiovascular medicine, the cardiology sector addresses the special requirements and difficulties connected with cardiac procedures.
North America commanded the largest market share during the extrapolated period owing to the benefits from a strong healthcare infrastructure, cutting-edge medical facilities, and a significant volume of operations across North America. Additionally, the adoption of contemporary anesthetic systems is driven by regulatory compliance and adherence to exacting safety requirements. The constant need for outstanding anesthetic equipment in North America is further fuelled by an aging population and rising healthcare costs. A significant number of well-known suppliers of anesthetic equipment are present in the market, and technical innovation is becoming increasingly important. Therefore, these aspects contribute to the market's expansion.
Europe is expected to witness highest CAGR over the projection period, owing to healthcare infrastructure, stringent regulatory standards, and a rising demand for advanced anesthesia solutions. Europe is a key and competitive region in the worldwide anesthetic equipment market because many European healthcare systems prioritize quality and efficiency. Therefore, this has led to a consistent demand for cutting-edge anaesthetic equipment, including monitoring devices and delivery systems.
Some of the key players in the Anesthesia Equipment Market include: Ambu A/S, B. Braun Melsungen AG, Becton Dickinson and Company, Dragerwerk AG & Co. KGaA, GE HealthCare Technologies, Inc., Getinge AB, Heyer Medical AG, Koninklijke Philips N.V., Medline Industries, Inc., Medtronic PLC, Penlon Ltd., Pentax, SunMed, LLC, Teleflex Incorporated and Ventlab.
In September 2023, Mayo Clinic and GE HealthCare announce a strategic healthcare collaboration for research and product development programs aimed to transform the experience of patients and clinicians in the practice of radiology and the delivery of novel therapies.
In July 2023, The American Society of Anesthesiologists (ASA) announced it has been selected as a 2023 Best and Brightest Companies to Work For in the Nation. This marks the seventh consecutive year the Society has received the designation.
In April 2022, GE Healthcare announced the FDA pre-market approval (PMA) for its End-tidal (Et) Control software for general anesthesia delivery on its Aisys CS2.